Skip to content

Clinical Efficacy Study of Transcranial Magnetic Stimulation Combined with Neurac Technology in Chronic Nonspecific Low Back Pain

Clinical Efficacy Study of Transcranial Magnetic Stimulation Combined with Neurac Technology in Chronic Nonspecific Low Back Pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116248
Enrollment
Unknown
Registered
2026-01-07
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Nonspecific Low Back Pain

Interventions

Repetitive Transcranial Magnetic Stimulation group:Repetitive Transcranial Magnetic Stimulation: High-frequency (10Hz) rTMS with a stimulation intensity of 80% of the resting motor threshold was appli
Neurac group:Neurac Neuromuscular Stimulation: Progressive neuromuscular activation training is conducted using the SET-Redcord Neurac system, scheduled three times per week.
Regular Group:Conventional Physical Therapy + Sham Stimulation: Conventional Physical Therapy + Sham Stimulation (30 minutes per session per day, 3 days per week, for a total of 4 weeks)
Joint Group:Transcranial Magnetic Stimulation + Neurac Group: rTMS intervention was administered immediately before each Neurac training session.

Sponsors

Chongqing Medical University Affiliated Rehabilitation Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Symptoms: Repeated pain in the waist or (and) the lumbosacral region, stiffness in the waist, no symptoms of nerve root compression (limited to the knee joint at the distal end), varying degrees of limited mobility in the waist; 2. Signs: May have signs such as tense waist muscles, positive local tenderness, limited lumbar range of motion, etc., but normal muscle strength, muscle tone, sensation, and reflexes in both lower limbs, negative straight leg raising test; 3. Imaging examination: No obvious abnormalities were found in X-rays and/or CT, MR, etc., or only mild degeneration of the lumbar intervertebral discs, bone hyperplasia, and changes in the physiological curvature of the lumbar spine were observed; 4. Course of disease: >= 3 months; 5. General condition: Age between 20 and 50 years old, body mass index less than 28 kg/m^2, stable vital signs, no other serious diseases in other systems; 6. All patients were able to perform work during the trial period; 7. Signed informed consent form

Exclusion criteria

Exclusion criteria: 1. History of lumbar trauma, fracture, dislocation, or surgery, or having performed lumbar muscle function exercises in the past 3 months; 2. Patients with positive neurological signs, motor deficits (such as flexibility, posture, or gait issues in both lower limbs), and imaging evidence of lumbar conditions such as spinal canal stenosis, spondylolisthesis, vertebral anterior displacement, or scoliosis; 3. Lumbar-specific or non-specific infectious diseases (e.g., lumbar tuberculosis); 4. Patients with severe cardiovascular, cerebrovascular, liver, kidney, or hematological diseases, neurological disorders, autoimmune or metabolic diseases, pregnant or postpartum women, psychiatric patients, or those with cognitive impairments who cannot cooperate with the study.

Design outcomes

Primary

MeasureTime frame
Pain level;Lumbar Functional Impairment Index(ODI);

Secondary

MeasureTime frame
Lumbar Joint Range of Motion (ROM);Lumbar Posture and Balance Assessment;Flexion Relaxation Ratio (FRR) and Muscle Activation Timing;Quality of Life Scale (SF-36);Anxiety and Depression Scale (HADS);Pain Catastrophizing Scale;

Countries

China

Contacts

Public ContactYang Zhenyou

Chongqing Medical University Affiliated Rehabilitation Hospital

15215014029@163.com+86 152 1501 4029

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026